Patanjali has been in the news for their claim of developing a medicine, that they believe, is a cure to COVID-19. The Ministry of AYUSH and the ICMR issued an order asking Patanjali to provide them with all the details and to stop advertising as long as the said medicine is not examined properly.
Soon after the official order, Patanjali responded by saying that they have submitted all the details to the Ministry. Patanjali CEO Acharya Balkrishna, issued a statement on Tuesday (23rd June, 2020), saying, “This government provides encouragement and pride to Ayurveda. The communication gap has been done away with and we have 100% fulfilled all standard parameters for Randomised Placebo-Controlled Clinical Trials. We’ve given information for the same to Ministry of AYUSH.”
Earlier in the day, Yoga Guru Ramdev introduced a medicine ceremonially named Coronil which, his company, Patanjali, claimed to be a cure to COVID-19. The Ministry of AYUSH and the ICMR, then issued an order, asking for details about the sample size, sites and hospitals where the research study was conducted and the Institutional Ethics Committee clearance.
Patanjali was asked to stop advertising as such advertisements of drugs including Ayurvedic medicines are regulated under the provisions of Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and Rules thereunder and the directives issued by the Central Government in the wake of COVID-19 outbreak.
The company claims that the medicine has showed 100% results during the clinical trial and could cure all the infected patients.